Growth Hormone Releasing Hormone Analog
CJC-1295
GHRH analog with extended half-life studied for sustained growth hormone release and IGF-1 elevation in research contexts.
Select Size
Tested by: Eurofins Scientific · Batch: VRC-CJC-2405 · May 2026
About CJC-1295
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) with a drug affinity complex (DAC) modification that enables covalent binding to serum albumin, dramatically extending its half-life compared to native GHRH. Preclinical and early clinical research has studied its ability to produce sustained, pulsatile GH release and elevate IGF-1 levels over extended periods. It is commonly used as a research tool in GH axis studies.
Research Areas
Technical Specifications
Molecular Weight
3647.28 g/mol
Amino Acid Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ (DAC)
Storage
Lyophilized: −20°C, stable 24 months. Reconstituted: 4°C, use within 28 days.
Solubility
Soluble in water at ≥1 mg/mL
For Research Purposes Only. CJC-1295 is sold exclusively for in vitro laboratory research. Not for human consumption, diagnostic, therapeutic, or veterinary use. See our Research Use Disclaimer.